Annual Revenue
$566.77 M
+$102.83 M+22.17%
December 31, 2023
Summary
- As of February 12, 2025, COLL annual revenue is $566.77 million, with the most recent change of +$102.83 million (+22.17%) on December 31, 2023.
- During the last 3 years, COLL annual revenue has risen by +$256.75 million (+82.82%).
- COLL annual revenue is now at all-time high.
Performance
COLL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$159.30 M
+$14.03 M+9.65%
September 30, 2024
Summary
- As of February 12, 2025, COLL quarterly revenue is $159.30 million, with the most recent change of +$14.03 million (+9.65%) on September 30, 2024.
- Over the past year, COLL quarterly revenue has increased by +$22.59 million (+16.53%).
- COLL quarterly revenue is now at all-time high.
Performance
COLL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$599.25 M
+$22.59 M+3.92%
September 30, 2024
Summary
- As of February 12, 2025, COLL TTM revenue is $599.25 million, with the most recent change of +$22.59 million (+3.92%) on September 30, 2024.
- Over the past year, COLL TTM revenue has increased by +$52.60 million (+9.62%).
- COLL TTM revenue is now at all-time high.
Performance
COLL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
COLL Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.2% | +16.5% | +9.6% |
| 3 y3 years | +82.8% | +16.5% | +9.6% |
| 5 y5 years | +102.1% | +16.5% | +9.6% |
COLL Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +104.7% | at high | +482.2% | at high | +119.6% |
| 5 y | 5-year | at high | +104.7% | at high | +482.2% | at high | +119.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Collegium Pharmaceutical Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $159.30 M(+9.7%) | $599.25 M(+3.9%) |
| Jun 2024 | - | $145.28 M(+0.2%) | $576.65 M(+1.7%) |
| Mar 2024 | - | $144.92 M(-3.2%) | $566.92 M(+0.0%) |
| Dec 2023 | $566.77 M(+22.2%) | $149.75 M(+9.5%) | $566.77 M(+3.7%) |
| Sep 2023 | - | $136.71 M(+0.9%) | $546.64 M(+1.8%) |
| Jun 2023 | - | $135.55 M(-6.4%) | $536.95 M(+2.3%) |
| Mar 2023 | - | $144.77 M(+11.7%) | $524.95 M(+13.2%) |
| Dec 2022 | $463.93 M(+67.6%) | $129.62 M(+2.1%) | $463.93 M(+28.3%) |
| Sep 2022 | - | $127.01 M(+2.8%) | $361.68 M(+15.4%) |
| Jun 2022 | - | $123.55 M(+47.5%) | $313.50 M(+14.9%) |
| Mar 2022 | - | $83.75 M(+206.1%) | $272.90 M(-1.4%) |
| Dec 2021 | $276.87 M(-10.7%) | $27.36 M(-65.3%) | $276.87 M(-15.0%) |
| Sep 2021 | - | $78.84 M(-4.9%) | $325.78 M(-0.1%) |
| Jun 2021 | - | $82.94 M(-5.4%) | $326.11 M(+1.5%) |
| Mar 2021 | - | $87.72 M(+15.0%) | $321.23 M(+3.6%) |
| Dec 2020 | $310.02 M | $76.27 M(-3.7%) | $310.02 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $79.18 M(+1.4%) | $307.95 M(+2.1%) |
| Jun 2020 | - | $78.06 M(+2.0%) | $301.71 M(+1.0%) |
| Mar 2020 | - | $76.51 M(+3.1%) | $298.70 M(+0.7%) |
| Dec 2019 | $296.70 M(+5.8%) | $74.20 M(+1.7%) | $296.70 M(+0.3%) |
| Sep 2019 | - | $72.94 M(-2.8%) | $295.93 M(+0.9%) |
| Jun 2019 | - | $75.04 M(+0.7%) | $293.16 M(+0.7%) |
| Mar 2019 | - | $74.52 M(+1.5%) | $291.18 M(+3.8%) |
| Dec 2018 | $280.41 M(+884.7%) | $73.43 M(+4.6%) | $280.41 M(+28.8%) |
| Sep 2018 | - | $70.18 M(-3.9%) | $217.78 M(+36.5%) |
| Jun 2018 | - | $73.06 M(+14.6%) | $159.55 M(+77.2%) |
| Mar 2018 | - | $63.75 M(+490.6%) | $90.05 M(+216.2%) |
| Dec 2017 | $28.48 M(+1564.3%) | $10.79 M(-9.7%) | $28.48 M(+50.0%) |
| Sep 2017 | - | $11.95 M(+235.7%) | $18.98 M(+155.1%) |
| Jun 2017 | - | $3.56 M(+63.9%) | $7.44 M(+91.7%) |
| Mar 2017 | - | $2.17 M(+66.7%) | $3.88 M(+126.9%) |
| Dec 2016 | $1.71 M | $1.30 M(+219.4%) | $1.71 M(+319.4%) |
| Sep 2016 | - | $408.00 K | $408.00 K |
FAQ
- What is Collegium Pharmaceutical annual revenue?
- What is the all time high annual revenue for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical annual revenue year-on-year change?
- What is Collegium Pharmaceutical quarterly revenue?
- What is the all time high quarterly revenue for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical quarterly revenue year-on-year change?
- What is Collegium Pharmaceutical TTM revenue?
- What is the all time high TTM revenue for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical TTM revenue year-on-year change?
What is Collegium Pharmaceutical annual revenue?
The current annual revenue of COLL is $566.77 M
What is the all time high annual revenue for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high annual revenue is $566.77 M
What is Collegium Pharmaceutical annual revenue year-on-year change?
Over the past year, COLL annual revenue has changed by +$102.83 M (+22.17%)
What is Collegium Pharmaceutical quarterly revenue?
The current quarterly revenue of COLL is $159.30 M
What is the all time high quarterly revenue for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high quarterly revenue is $159.30 M
What is Collegium Pharmaceutical quarterly revenue year-on-year change?
Over the past year, COLL quarterly revenue has changed by +$22.59 M (+16.53%)
What is Collegium Pharmaceutical TTM revenue?
The current TTM revenue of COLL is $599.25 M
What is the all time high TTM revenue for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high TTM revenue is $599.25 M
What is Collegium Pharmaceutical TTM revenue year-on-year change?
Over the past year, COLL TTM revenue has changed by +$52.60 M (+9.62%)